The RAIN Study, a Multicenter Randomized Double-blind Phase 2b Study of NEOD001 in Previously Treated Subjects With Systemic Light-chain (AL) Amyloidosis and Persistent Renal Involvement
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2017
At a glance
- Drugs NEOD 001 (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- Acronyms RAIN
- 06 Jul 2017 Planned End Date changed from 1 Jun 2019 to 1 Jul 2019.
- 06 Jul 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Jul 2019.
- 06 Jul 2017 Status changed from not yet recruiting to recruiting.